Cargando…
mTOR-dependent signalling in Alzheimer's disease
Neurodegeneration and neurofibrillary degeneration are the two main pathological mechanisms of cognitive impairments in Alzheimer's disease (AD). It is not clear what factors determine the fates of neurons during the progress of the disease. Emerging evidence has suggested that mTOR-dependent s...
Autores principales: | Pei, Jin-Jing, Hugon, Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828871/ https://www.ncbi.nlm.nih.gov/pubmed/19210753 http://dx.doi.org/10.1111/j.1582-4934.2008.00509.x |
Ejemplares similares
-
Activation of mTOR: a culprit of Alzheimer’s disease?
por: Cai, Zhiyou, et al.
Publicado: (2015) -
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020) -
mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019) -
mTOR signaling in skeletal development and disease
por: Chen, Jianquan, et al.
Publicado: (2018) -
All PI3Kinase signaling is not mTOR: dissecting mTOR-dependent and independent signaling pathways in T cells
por: Gamper, Christopher J., et al.
Publicado: (2012)